Xiaojun Wang serves as an Associate Vice President, bringing over two decades of experience in the field of drug discovery. Their expertise primarily lies in metabolic disease, diabetes, and diabetes complications. Throughout their career, Wang has been instrumental in advancing scientific initiatives, successfully leading multiple projects from discovery phases to the development of clinical candidates.